language_icon
EN
HI

Johnson Pharmacare Share price

JOHNPHARMA

0.55

0.00 (0.00%)
Last updated on 2 Jun, 2026 | 15:56 IST
Today's High

0.55

Today's Low

0.54

52 Week Low

0.47

52 Week High

0.93

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Johnson Pharmacare Chart

Johnson Pharmacare Share Key Metrics

Volume
4.68 L
Market Cap
30.25 CR
LTQ@LTP
25@0.55
ATP
0.54
Var Margin
100 %
Circuit Range
0.44-0.66
Delivery %
53.37 %
Value
2.53 L
ASM/GSM
No
Market Lot
1

Summary

Johnson Pharmacare share price is ₹0.55 as of 2 Jun, 2026. The stock Johnson Pharmacare intraday movement has stayed between ₹0.54 and ₹0.55, while on a 52-week basis,Johnson Pharmacare price 52 week high is ₹0.93 & its 52 week low is ₹0.47.
In terms of trading activity, Johnson Pharmacare has recorded a volume of 468258 shares, The Johnson Pharmacare has a market cap of ₹550000000 CR. The stock’s Average Traded Price (ATP) stands at ₹0.54, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 25 @ ₹0.55.
Johnson Pharmacare operates within a circuit range of ₹0.44 – ₹0.66, with a Value of ₹2.53 L. The Delivery Percentage for the day is 53.37%. Additionally, Johnson Pharmacare currently falls under the No framework, and trades with a market lot size of 1.

Johnson Pharmacare Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

40.39

Sector P/B

2.22

Sec. Div. Yield

78.54

Johnson Pharmacare Resistance and Support

Pivot 0.54

Resistance

First Resistance

0.55

Second Resistance

0.56

Third Resistance

0.57

Support

First Support

0.53

Second Support

0.52

Third Support

0.51

Johnson Pharmacare Shareholding Pattern

View More
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

0%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

100%

Others

0%

Total Promoters
MAR '26
0%

Johnson Pharmacare Corporate Actions

DateAgenda
2026-05-27Audited Results
2026-02-14Quarterly Results
2026-02-12Quarterly Results
2025-11-14Quarterly Results
2025-07-23Quarterly Results
2025-05-23Audited Results
2025-01-31Quarterly Results

Johnson Pharmacare News

Johnson Pharmacare Ltd - 532154 - Outcome Of Meeting Of Board Of Directors Held On Wednesday, 27Th May, 2026 At Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

Johnson Pharmacare's FY26 financial statements received a qualified audit opinion, with auditors noting non-provision of interest on loans, non-compliance with Ind AS, and internal control deficiencies. The company explicitly stated its inability to meet liabilities and reported a significant cash loss of Rs. 111.23 cr for the year. Additionally, it faces non-compliance with RBI regulations for NBFC/CIC criteria.
Jun 01 2026 13:48:10

Johnson Pharmacare Ltd - 532154 - Disclosure Of Related Party Transaction Pursuant To Regulation 23(9) Of Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirements) Regulations, 2015.

Johnson Pharmacare has confirmed that it did not enter into any related party transactions during the fiscal year ended March 31, 2026. This disclosure fulfills the company's compliance obligations under SEBI Regulation 23(9).
May 27 2026 19:57:26

Johnson Pharmacare Ltd - 532154 - Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Held On Wednesday, 27Th May, 2026 At Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

Johnson Pharmacare's board approved FY26 audited financial results, reporting a net loss of ₹55.73 crores and revenue of ₹1.58 crores. Auditors issued a qualified opinion, highlighting significant internal control deficiencies and non-compliance with IND-AS, also noting the company's inability to meet liabilities. Two directors resigned.
May 27 2026 19:46:28

Johnson Pharmacare Ltd - 532154 - Board Meeting Intimation for Prior Intimation Of Board Meeting For Approval Of Audited Financial Results For The Quarter & Year Ended On 31St March, 2026.

Johnson Pharmacare will hold a board meeting on May 27, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026. This meeting will finalize the company's financial performance for the last quarter and full fiscal year.
May 22 2026 19:08:58
Read More

Johnson Pharmacare Management

NamePosition
Ramanlal TrivediWhole Time Director & Chief Financial Officer
Manisha Maneklal PatelNon Executive Independent Director
View More

Johnson Pharmacare FAQs

The Buying Price of Johnson Pharmacare share is 0.55 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Johnson Pharmacare stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Johnson Pharmacare, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Johnson Pharmacare shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Johnson Pharmacare shares is 0. Useful to assess the stock's value relative to its book value.

To assess Johnson Pharmacare’s valuation compare Sector P/E, P/B which are 40.39 & 2.22 with sector averages, along with growth rates and financial metrics.

The Market Cap of Johnson Pharmacare is 30.25 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Johnson Pharmacare share price is 0.93 & 0.47. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Johnson Pharmacare belongs to the Miscellaneous sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost